Compare · head to head
Chunghwa Chemical Synthesis & Biotech vs Panion & Bf Biotech
Panion & Bf Biotech ranks higher overall — 360 rank 84 vs 13.
Panion & Bf Biotech leads on Value (41 vs 28), Quality (72 vs 43), Growth (62 vs 48) and Safety (65 vs 42). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Taiwan | Taiwan |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Small | Small |
| ISIN | TW0001762003 | TW0001760007 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 13 | 84 |
| Value | 28 | 41 |
| Quality | 43 | 72 |
| Growth | 48 | 62 |
| Safety | 42 | 65 |
| Sentiment | 44 | 47 |
| Quality details | ||
| Profitability | 33 | 87 |
| Cash Truth | 53 | 58 |
Chunghwa Chemical Synthesis & Biotech vs PKCChunghwa Chemical Synthesis & Biotech vs NOVONIXChunghwa Chemical Synthesis & Biotech vs Kukje PharmaChunghwa Chemical Synthesis & Biotech vs PharmGen ScienceAdd a third stock →
Full analyses: Chunghwa Chemical Synthesis & Biotech · Panion & Bf Biotech
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100